KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Other Non-Current Liabilities (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Other Non-Current Liabilities for 16 consecutive years, with $4.3 billion as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Other Non-Current Liabilities changed 0.39% year-over-year to $4.3 billion, compared with a TTM value of $4.3 billion through Sep 2024, changed 0.39%, and an annual FY2023 reading of $4.6 billion, up 9.53% over the prior year.
  • Other Non-Current Liabilities was $4.3 billion for Q3 2024 at Thermo Fisher Scientific, down from $4.4 billion in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $4.7 billion in Q2 2022 and bottomed at $3.3 billion in Q1 2020.
  • Average Other Non-Current Liabilities over 5 years is $4.1 billion, with a median of $4.2 billion recorded in 2022.
  • The sharpest move saw Other Non-Current Liabilities soared 39.14% in 2022, then fell 10.85% in 2023.
  • Year by year, Other Non-Current Liabilities stood at $3.3 billion in 2020, then skyrocketed by 36.34% to $4.5 billion in 2021, then decreased by 6.65% to $4.2 billion in 2022, then increased by 9.53% to $4.6 billion in 2023, then fell by 6.44% to $4.3 billion in 2024.
  • Business Quant data shows Other Non-Current Liabilities for TMO at $4.3 billion in Q3 2024, $4.4 billion in Q2 2024, and $4.6 billion in Q1 2024.